Apollo Hospitals plan

Apollo's new entity will become an Indian Owned and Controlled Company (IOCC) and will apply for listing on the stock exchanges within 18-21 months. The board of directors of

and Apollo HealthCo, a subsidiary of the healthcare major, have accorded in-principal approval for the composite scheme of arrangement. The scheme entails the demerger of the Omni Channel Pharma and Digital Health business—comprising the telehealth business of Apollo and its investment in Apollo HealthCo Limited (AHL)—into a new entity. Following the demerger, the scheme provides for the amalgamation of AHL with the new entity. Keimed Pvt Ltd, India's leading wholesale pharmaceutical distributor, will subsequently amalgamate with the new entity, NewCo. The scheme creates a formidable omnichannel pharmacy distribution and digital health platform leader in India, with stated plans to achieve ₹25,000 crore revenue by FY27, Apollo Hospitals Enterprise said in a regulatory filing. Upon the effectiveness of the scheme, the new entity will become an Indian Owned and Controlled Company (IOCC) and will apply for listing on the stock exchanges, it added. The listing is expected within 18-21 months, the healthcare major said. Upon becoming an IOCC, the entity also proposes to consolidate the front-end pharmacy business by acquiring the remaining 74.5% stake in Apollo Medicals Pvt Ltd (AMPL), which owns 100% of Apollo Pharmacies Limited (APL). Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.